Skip to main content
. Author manuscript; available in PMC: 2010 Jun 24.
Published in final edited form as: Bioorg Med Chem. 2009 Jul 5;17(17):6463–6480. doi: 10.1016/j.bmc.2009.05.085

Figure 2.

Figure 2

Schematic of the NMDA receptor antagonist pharmacophore (7) compared to an NR2B-selective enantiomeric propanolamine (8) and an NR2B-selective screening hit (9).